These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 24282819)
61. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment. Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721 [TBL] [Abstract][Full Text] [Related]
62. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay. Zhang C; Wu Y; Dong Y; Xu H; Zhao L Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143 [TBL] [Abstract][Full Text] [Related]
63. Synthesis, characterization and in vitro digestion of folate conjugated chitosan-loaded proanthocyanidins nanoparticles. Ding Z; Chen W; Jiang F; Mo M; Bi Y; Kong F Food Res Int; 2023 Jan; 163():112141. PubMed ID: 36596096 [TBL] [Abstract][Full Text] [Related]
64. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study. Kumar P; Tambe P; Paknikar KM; Gajbhiye V Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877 [TBL] [Abstract][Full Text] [Related]
65. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification. Zhang S; Tang C; Yin C Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373 [TBL] [Abstract][Full Text] [Related]
66. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics. Wang F; Wang Y; Ma Q; Cao Y; Yu B Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196 [TBL] [Abstract][Full Text] [Related]
67. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid. Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607 [TBL] [Abstract][Full Text] [Related]
68. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin. Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730 [TBL] [Abstract][Full Text] [Related]
69. Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy. Chen W; Li J; Xing Y; Wang X; Zhang H; Xia M; Wang D Pharm Res; 2020 Jul; 37(7):134. PubMed ID: 32642819 [TBL] [Abstract][Full Text] [Related]
70. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line. Erdem M; Yalcin S; Gunduz U Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842 [TBL] [Abstract][Full Text] [Related]
71. Effect of targeting ligand designation of self-assembly chitosan-poloxamer nanogels loaded Paclitacel on inhibiting MCF-7 cancer cell growth. Nguyen VT; Doan P; Nguyen DT; Doan VD; Dao TP; Plavskii V; Nguyen BT; Tran NQ J Biomater Sci Polym Ed; 2022 Mar; 33(4):426-442. PubMed ID: 34641768 [TBL] [Abstract][Full Text] [Related]
72. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells. Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994 [TBL] [Abstract][Full Text] [Related]
73. Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death. Phung CD; Nguyen HT; Choi JY; Pham TT; Acharya S; Timilshina M; Chang JH; Kim JH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO J Control Release; 2019 Dec; 315():126-138. PubMed ID: 31672625 [TBL] [Abstract][Full Text] [Related]
74. pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells. Luesakul U; Puthong S; Neamati N; Muangsin N Carbohydr Polym; 2018 Feb; 181():841-850. PubMed ID: 29254044 [TBL] [Abstract][Full Text] [Related]
76. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment. Kunjiappan S; Panneerselvam T; Govindaraj S; Parasuraman P; Baskararaj S; Sankaranarayanan M; Arunachalam S; Babkiewicz E; Jeyakumar A; Lakshmanan M Anticancer Agents Med Chem; 2019; 19(16):1966-1982. PubMed ID: 31267878 [TBL] [Abstract][Full Text] [Related]
77. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887 [TBL] [Abstract][Full Text] [Related]
78. Targeted H Deng Z; Tang M; Zhao L; Long Y; Wen Z; Cheng Y; Zheng H Colloids Surf B Biointerfaces; 2017 Dec; 160():207-214. PubMed ID: 28934664 [TBL] [Abstract][Full Text] [Related]
79. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma. Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436 [TBL] [Abstract][Full Text] [Related]
80. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Misra R; Sahoo SK Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]